Genzyme, Apple, Royal Worcester: Intellectual Property

Shelbyzyme LLC, the owner of a patent used to treat organ-destroying Fabry disease, won $50 million from Genzyme Corp. after a jury trial.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.